Paradigm Biocapital Advisors as of Dec. 31, 2021
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 24 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 10.9 | $38M | 260k | 146.69 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 8.4 | $29M | 218k | 134.53 | |
| Zentalis Pharmaceuticals (ZNTL) | 7.2 | $25M | 300k | 84.06 | |
| Miragen Therapeutics (VRDN) | 6.8 | $24M | 1.2M | 19.77 | |
| Arena Pharmaceuticals Com New | 6.7 | $23M | 252k | 92.94 | |
| Global Blood Therapeutics In | 6.5 | $23M | 781k | 29.27 | |
| Arvinas Ord (ARVN) | 6.3 | $22M | 269k | 82.14 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.1 | $18M | 386k | 46.61 | |
| Iovance Biotherapeutics (IOVA) | 4.6 | $16M | 844k | 19.09 | |
| Seagen | 4.4 | $16M | 101k | 154.60 | |
| Argenx Se Sponsored Adr (ARGX) | 4.2 | $15M | 42k | 350.18 | |
| Iveric Bio | 3.9 | $14M | 816k | 16.72 | |
| Insmed Com Par $01 (INSM) | 3.1 | $11M | 394k | 27.24 | |
| Sierra Oncology Com New | 2.9 | $10M | 475k | 21.74 | |
| Syndax Pharmaceuticals (SNDX) | 2.8 | $9.9M | 453k | 21.89 | |
| Galapagos Nv Spon Adr (GLPG) | 2.6 | $9.3M | 168k | 55.13 | |
| C4 Therapeutics Com Stk (CCCC) | 2.4 | $8.3M | 259k | 32.20 | |
| Kymera Therapeutics (KYMR) | 2.3 | $8.0M | 126k | 63.49 | |
| Vor Biopharma (VOR) | 2.1 | $7.3M | 629k | 11.62 | |
| Enanta Pharmaceuticals (ENTA) | 1.6 | $5.6M | 76k | 74.77 | |
| Oyster Point Pharma | 1.6 | $5.6M | 304k | 18.26 | |
| Immunocore Hldgs Ads (IMCR) | 1.3 | $4.6M | 134k | 34.24 | |
| Esperion Therapeutics (ESPR) | 1.2 | $4.2M | 839k | 5.00 | |
| Gracell Biotechnologies Sponsored Ads | 0.9 | $3.3M | 545k | 6.04 |
